Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development

Overview of attention for article published in Clinical Ophthalmology, June 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 102 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 49 publications that cite this research output.

49

The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.

Short-Term Real-World Outcomes of Intensive Aflibercept Injection for Refractory Neovascular Age-Related Macular Degeneration

Article in Journal of Clinical Medicine (June 2024)

Topical Solution for Retinal Delivery: Bevacizumab and Ranibizumab Eye Drops in Anti-Aggregation Formula (AAF) in Rabbits

Article in Pharmaceutical Research (June 2024)

Dose-Related Side Effects of Intravitreal Injections of Humanized Anti-Vascular Endothelial Growth Factor in Rats: Glial Cell Reactivity and Retinal Ganglion Cell Loss

Article in Investigative Ophthalmology & Visual Science (April 2024)